knockout crispr library v1 (Addgene inc)
Structured Review
Knockout Crispr Library V1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+improved+genome+wide+knockout+crispr+library+v1/Human+Improved+Genome-wide+Knockout+CRISPR+Library+(Pooled+Library+%2367989)/pmc12730985-0-24-28
Average 95 stars, based on 50 article reviews
Images
Related Articles
Genome Wide:Article Title: Development of a Synthetic Lethality‐Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer Article Snippet: .. We used the Article Title: Interferon-Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma. Article Snippet: .. Particularly, two sgRNA sequences were used for ADAR1: ADAR1‐sg1K or “A1K” from the Knock-Out:Article Title: Development of a Synthetic Lethality‐Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer Article Snippet: .. We used the Article Title: Interferon-Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma. Article Snippet: .. Particularly, two sgRNA sequences were used for ADAR1: ADAR1‐sg1K or “A1K” from the CRISPR:Article Title: Development of a Synthetic Lethality‐Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer Article Snippet: .. We used the Article Title: Interferon-Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma. Article Snippet: .. Particularly, two sgRNA sequences were used for ADAR1: ADAR1‐sg1K or “A1K” from the |

